T2 Biosystems Inc. [NASDAQ: TTOO] surged by $0.01 during the normal trading session on Friday and reaching a high of $0.1185 during the day while it closed the day at $0.12. The company report on September 8, 2022 that T2 Biosystems to Participate in the H.C. Wainwright Global Investment Conference.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to participate in the upcoming H.C. Wainwright Global Investment Conference in New York, New York.
Management is scheduled to present on Tuesday, September 13, 2022, at 3:00pm ET. Interested parties may access a live and recorded webcast of the presentation on the “Investors” section of the Company’s website at www.t2biosystems.com.
T2 Biosystems Inc. stock has also loss 0.00% of its value over the past 7 days. However, TTOO stock has declined by -38.10% in the 3 months of the year. Over the past six months meanwhile, it has lost -71.05% and lost -77.33% year-on date.
The market cap for TTOO stock reached $39.80 million, with 352.54 million shares outstanding and 344.05 million shares in the current float. Compared to the average trading volume of 40.59M shares, TTOO reached a trading volume of 15505422 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about T2 Biosystems Inc. [TTOO]:
Alliance Global Partners have made an estimate for T2 Biosystems Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on January 27, 2021. While these analysts kept the previous recommendation, BTIG Research raised their target price to Buy. The new note on the price target was released on October 08, 2020, representing the official price target for T2 Biosystems Inc. stock.
The Average True Range (ATR) for T2 Biosystems Inc. is set at 0.02, with the Price to Sales ratio for TTOO stock in the period of the last 12 months amounting to 1.44.
TTOO stock trade performance evaluation
T2 Biosystems Inc. [TTOO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by 0.00. With this latest performance, TTOO shares dropped by -25.95% in over the last four-week period, additionally sinking by -71.05% over the last 6 months – not to mention a drop of -86.50% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TTOO stock in for the last two-week period is set at 42.90, with the RSI for the last a single of trading hit 43.24, and the three-weeks RSI is set at 42.71 for T2 Biosystems Inc. [TTOO]. The present Moving Average for the last 50 days of trading for this stock 0.1395, while it was recorded at 0.1122 for the last single week of trading, and 0.3324 for the last 200 days.
T2 Biosystems Inc. [TTOO]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and T2 Biosystems Inc. [TTOO] shares currently have an operating margin of -153.16 and a Gross Margin at +26.21. T2 Biosystems Inc.’s Net Margin is presently recorded at -175.50.
T2 Biosystems Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.40 and a Current Ratio set at 1.90.
T2 Biosystems Inc. [TTOO]: Insider Ownership positions
There are presently around $2 million, or 5.50% of TTOO stock, in the hands of institutional investors. The top three institutional holders of TTOO stocks are: VANGUARD GROUP INC with ownership of 9,088,832, which is approximately 80.835% of the company’s market cap and around 0.50% of the total institutional ownership; BLACKROCK INC., holding 2,566,595 shares of the stock with an approximate value of $0.3 million in TTOO stocks shares; and GEODE CAPITAL MANAGEMENT, LLC, currently with $0.18 million in TTOO stock with ownership of nearly -2.697% of the company’s market capitalization.
Positions in T2 Biosystems Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 14 institutional holders increased their position in T2 Biosystems Inc. [NASDAQ:TTOO] by around 4,864,552 shares. Additionally, 29 investors decreased positions by around 1,059,615 shares, while 35 investors held positions by with 13,109,671 shares. The mentioned changes placed institutional holdings at 19,033,838 shares, according to the latest SEC report filing. TTOO stock had 5 new institutional investments in for a total of 215,626 shares, while 11 institutional investors sold positions of 315,610 shares during the same period.